Exposure to potential drug-antimicrobial agent interactions in primary health care

被引:1
作者
Nikolic, Bozana [1 ,2 ]
Popovic, Jovan [3 ]
Becarevic, Mirjana [2 ]
Rakic, Dusica [1 ,4 ]
机构
[1] Hlth Ctr Novi Sad, Novi Sad, Serbia
[2] Univ Novi Sad, Fac Med, Dept Pharm, Hajduk Veljkova 3, Novi Sad 21000, Serbia
[3] Univ Novi Sad, Fac Med, Dept Pharmacol & Toxicol, Novi Sad, Serbia
[4] Univ Novi Sad, Fac Med, Dept Gen Educ Subjects, Novi Sad, Serbia
关键词
drug therapy; anti-bacterial agents; drug interactions; outpatients; adverse drug reaction reporting systems; pharmacovigilance; RISK; PHARMACOKINETICS; POLYPHARMACY; INHIBITION; METABOLISM; ANTACIDS;
D O I
10.2298/VSP160930383N
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim. Drug-drug interactions involving antimicrobials present important and often unrecognized complications of pharmacotherapy which can be prevented. The aim of the present study was to identify the frequency and type of potential drug-antimicrobial agent interactions among outpatients and to define recommendations for their management. Methods. Cross-sectional prescription database study was conducted. The analysis randomly included 823 patients who visited Health Center Novi Sad over 1-month period (November 1-30, 2011) and had prescribed >= 2 drugs where at least one drug was antimicrobial agent for systemic use. All interacting drug combinations involving antimicrobials were identified according to Drug Interaction Facts. Additionally, based on the compendium, potential interactions were classified into categories: pharmacological mechanisms, potential clinical outcomes and management advice. Results. Overall, 88 potential clinically significant drug-antimicrobial agent interactions were identified among 69 (8.4%) exposed outpatients [ the mean age 61.7 years (SD +/- 15.4); the mean number of prescribed drugs 7.5 (SD +/- 2.9); 56.5% females]. The most common identified potential interacting pairs were benzodiazepines undergoing oxidative metabolism and clarithromycin or erythromycin, and aminophylline and ciprofloxacin. In 83.0% of all cases underlying mechanism was pharmacokinetic involving primary inhibition of metabolic pathways mediated by CYP3A4 and CYP1A2 isoenzymes. Excessive sedation (22.7%), cardiotoxicity (20.5%), miscellaneous aminophylline adverse effects (13.6%), and bleeding (10.2%) were the most frequently implicated potential clinical outcomes. Risk for adverse interactions could be managed by close monitoring of simultaneous administration of drugs (37.5%), different risk-modifyng strategies (31.8%), and avoiding combinations (30.7%). Conclusion. Among outpatients, there was common potential for clinically significant interactions involving antimicrobials. Information based on the results of the present study could be integrated in existing computerized physician order entry system in the Health Center as a form of clinical support.
引用
收藏
页码:795 / 802
页数:8
相关论文
共 50 条
[31]   Drug interactions in maternal intensive care: prevalence, risk factors, and potential risk medications [J].
Pessoa, Thiago de Lima ;
Clemente Junior, Washington Sales ;
da Costa, Tatiana Xavier ;
do Vale Bezerra, Priscilla Karilline ;
Martins, Rand Randall .
EINSTEIN-SAO PAULO, 2019, 17 (03) :eAO4521
[32]   POTENTIAL DRUG INTERACTIONS IN INTENSIVE CARE PATIENTS AT A TEACHING HOSPITAL [J].
Fontenele Lima, Rhanna Emanuela ;
De Bortoli Cassiani, Silvia Helena .
REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2009, 17 (02) :222-227
[33]   Potential antimicrobial drug interactions in clinical practice: consequences of polypharmacy and multidrug resistance [J].
Martinez-Mugica, Cristina .
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 (06) :282-288
[34]   DRUG-INTERACTIONS IN PRIMARY HEALTH-CARE - PROSPECTIVE-STUDY OF 896 PATIENTS TREATED FOR HYPERTENSION [J].
PAILLE, F ;
PISSOCHET, P .
THERAPIE, 1995, 50 (03) :253-258
[35]   Prevalence and Predictors of Potential Drug-Drug Interactions in the Elderly: A Cross-Sectional Study in the Brazilian Primary Public Health System [J].
Obreli Neto, Paulo Roque ;
Nobili, Alessandro ;
Marusic, Srecko ;
Pilger, Diogo ;
Guidoni, Camilo Molino ;
Baldoni, Andre de Oliveira ;
Cruciol-Souza, Joice Mara ;
da Cruz, Alessandra Negri ;
Gaeti, Walderez Penteado ;
Nakamura Cuman, Roberto Kenji .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2012, 15 (02) :344-354
[36]   Investigation of polypharmacy, antimicrobial-related potential drug-drug interactions in patients with hematological malignancies [J].
Oktay, Zeynep ;
Guner, Rahmet ;
Kayaaslan, Bircan ;
Hasanoglu, Imran ;
Kalem, Ayse Kaya ;
Ozet, Gulsum .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (04) :587-596
[37]   Variable Linezolid Exposure in Intensive Care Unit PatientsPossible Role of Drug-Drug Interactions [J].
Toepper, Christoph ;
Steinbach, Catherine L. ;
Dorn, Christoph ;
Kratzer, Alexander ;
Wicha, Sebastian G. ;
Schleibinger, Michael ;
Liebchen, Uwe ;
Kees, Frieder ;
Salzberger, Bernd ;
Kees, Martin G. .
THERAPEUTIC DRUG MONITORING, 2016, 38 (05) :573-578
[38]   Risk factors for potential drug-drug interactions in intensive care unit patients [J].
Jankovic, Slobodan M. ;
Pejcic, Ana V. ;
Milosavljevic, Milos N. ;
Opancina, Valentina D. ;
Pesic, Nikola V. ;
Nedeljkovic, Tamara T. ;
Babic, Goran M. .
JOURNAL OF CRITICAL CARE, 2018, 43 :1-6
[39]   Evaluation of Potential Drug-Drug Interactions with Antidepressants in Two Tertiary Care Hospitals [J].
Rafi, Muhammad Salman ;
Nagvi, Syed Bagir Shyum ;
Khan, Muhammad Umair ;
Fayyaz, Muhammad ;
Ashraf, Nida ;
Khan, Maosood Ahmed ;
Ahmad, Akram ;
Dhingra, Sameer .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (07) :FC05-FC08
[40]   Reducing drug interactions in primary care. A before and after study [J].
Lard, Roxane .
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2024, (208) :452-453